NeuroMetrix (NURO) Reports Q2 adj.-Loss of $0.92/Share

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/5/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. FIS
7. CVS
8. SPY
9. SWKS
10. XYZ

Go back to NeuroMetrix (NURO) Reports Q2 adj.-Loss of $0.92/Share

NeuroMetrix Reports Q2 2016 Financial Results and Highlights

July 21, 2016 7:00 AM EDT

Revenue Up 116% year-over-year to $2.6 Million 11,201 Quell Devices Shipped Expanded Retail Availability of Quell to over 1,500 retail stores

WALTHAM, Mass.--(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO), today reported financial and business highlights for the quarter and six month periods ended June 30, 2016.

The Company operates in two markets - wearable therapeutic technology and point-of-care diagnostic tests. The Companys two primary products are Quell® and DPNCheck®. Quell is an over-the-counter wearable neurostimulation device for treating chronic pain that was launched in... More